List of Tables

Table 1. Oral Peptide Therapy Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Oral Peptide Therapy Market Restraints

Table 3. Oral Peptide Therapy Market Trends

Table 4. Oral Peptide Therapy Industry Policy

Table 5. Global Oral Peptide Therapy Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Oral Peptide Therapy Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Oral Peptide Therapy Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Oral Peptide Therapy Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Oral Peptide Therapy Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Oral Peptide Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Oral Peptide Therapy Mergers & Acquisitions, Expansion Plans

Table 12. Global Oral Peptide Therapy Manufacturers Product Type

Table 13. Head Office and Oral Peptide Therapy Production Site of Key Manufacturer

Table 14. Oral Peptide Therapy Capacity of Major Manufacturers and Future Plan

Table 15. China Oral Peptide Therapy Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Oral Peptide Therapy Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Oral Peptide Therapy Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Oral Peptide Therapy Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Oral Peptide Therapy Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Oral Peptide Therapy Production by Region, 2020-2025, (K Units)

Table 21. Global Oral Peptide Therapy Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Oral Peptide Therapy Upstream (Raw Materials)

Table 23. Global Oral Peptide Therapy Typical Customers

Table 24. Oral Peptide Therapy Typical Distributors

Table 25. by Type, Global Oral Peptide Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Oral Peptide Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Oral Peptide Therapy Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Oral Peptide Therapy Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Oral Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Oral Peptide Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Oral Peptide Therapy Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Oral Peptide Therapy Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Oral Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Oral Peptide Therapy Sales Quantity Market Share, 2020-2031

Table 35. Allergan Company Information, Head Office, Market Area, and Industry Position

Table 36. Allergan Oral Peptide Therapy Models, Specifications, and Application

Table 37. Allergan Oral Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. Allergan Company Profile and Main Business

Table 39. Allergan Recent Developments

Table 40. Novo Nordisk Company Information, Head Office, Market Area, and Industry Position

Table 41. Novo Nordisk Oral Peptide Therapy Models, Specifications, and Application

Table 42. Novo Nordisk Oral Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. Novo Nordisk Company Profile and Main Business

Table 44. Novo Nordisk Recent Developments

Table 45. Synergy Pharmaceuticals （Salix） Company Information, Head Office, Market Area, and Industry Position

Table 46. Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Models, Specifications, and Application

Table 47. Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Synergy Pharmaceuticals （Salix） Company Profile and Main Business

Table 49. Synergy Pharmaceuticals （Salix） Recent Developments

Table 50. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 51. Novartis Oral Peptide Therapy Models, Specifications, and Application

Table 52. Novartis Oral Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Novartis Company Profile and Main Business

Table 54. Novartis Recent Developments

Table 55. Chiasma Company Information, Head Office, Market Area, and Industry Position

Table 56. Chiasma Oral Peptide Therapy Models, Specifications, and Application

Table 57. Chiasma Oral Peptide Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. Chiasma Company Profile and Main Business

Table 59. Chiasma Recent Developments

List of Figures

Figure 1. Oral Peptide Therapy Picture

Figure 2. Global Oral Peptide Therapy Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Oral Peptide Therapy Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Oral Peptide Therapy Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Oral Peptide Therapy Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Oral Peptide Therapy Sales Quantity (K Units) & (2020-2031)

Figure 7. China Oral Peptide Therapy Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Oral Peptide Therapy Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Oral Peptide Therapy Market Share of Global, 2020-2031

Figure 10. Global Oral Peptide Therapy Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Oral Peptide Therapy Key Participants, Market Share, 2024

Figure 12. Global Oral Peptide Therapy Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Oral Peptide Therapy Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Oral Peptide Therapy Production Market Share & Forecast by Region, 2020-2031

Figure 15. Oral Peptide Therapy Industry Chain

Figure 16. Oral Peptide Therapy Procurement Model

Figure 17. Oral Peptide Therapy Sales Model

Figure 18. Oral Peptide Therapy Sales Channels, Direct Sales, and Distribution

Figure 19. Linaclotide

Figure 20. Insulin

Figure 21. Plecanatide

Figure 22. Cyclosporine

Figure 23. Octreotide

Figure 24. by Type, Global Oral Peptide Therapy Consumption Value, 2020-2031, US$ Million

Figure 25. by Type, Global Oral Peptide Therapy Consumption Value Market Share, 2020-2031

Figure 26. by Type, Global Oral Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 27. by Type, Global Oral Peptide Therapy Sales Quantity Market Share, 2020-2031

Figure 28. by Type, Global Oral Peptide Therapy Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 29. Hospital

Figure 30. Retail Pharmacy

Figure 31. by Application, Global Oral Peptide Therapy Consumption Value, 2020-2031, US$ Million

Figure 32. by Application, Global Oral Peptide Therapy Revenue Market Share, 2020-2031

Figure 33. by Application, Global Oral Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 34. by Application, Global Oral Peptide Therapy Sales Quantity Market Share, 2020-2031

Figure 35. by Application, Global Oral Peptide Therapy Price, 2020-2031, (US$/Unit)

Figure 36. By Region, Global Oral Peptide Therapy Consumption Value Market Share, 2020-2031

Figure 37. By Region, Global Oral Peptide Therapy Sales Quantity Market Share, 2020-2031

Figure 38. North America Oral Peptide Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 39. By Country, North America Oral Peptide Therapy Consumption Value Market Share, 2024

Figure 40. Europe Oral Peptide Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 41. By Country, Europe Oral Peptide Therapy Consumption Value Market Share, 2024

Figure 42. Asia Pacific Oral Peptide Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 43. By Country/Region, Asia Pacific Oral Peptide Therapy Consumption Value Market Share, 2024

Figure 44. South America Oral Peptide Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 45. By Country, South America Oral Peptide Therapy Consumption Value Market Share, 2024

Figure 46. Middle East & Africa Oral Peptide Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 47. United States Oral Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 48. by Type, United States Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 49. by Application, United States Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 50. Europe Oral Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 51. by Type, Europe Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 52. by Application, Europe Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 53. China Oral Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 54. by Type, China Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 55. by Application, China Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 56. Japan Oral Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 57. by Type, Japan Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 58. by Application, Japan Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 59. South Korea Oral Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 60. by Type, South Korea Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 61. by Application, South Korea Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 62. Southeast Asia Oral Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 63. by Type, Southeast Asia Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 64. by Application, Southeast Asia Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 65. India Oral Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 66. by Type, India Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 67. by Application, India Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 68. Middle East & Africa Oral Peptide Therapy Sales Quantity, 2020-2031, (K Units)

Figure 69. by Type, Middle East & Africa Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 70. by Application, Middle East & Africa Oral Peptide Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 71. Research Methodology

Figure 72. Breakdown of Primary Interviews

Figure 73. Bottom-up Approaches

Figure 74. Top-down Approaches